← American Pharmacists Association (APhA)
FDANonrulemakingFDA-2018-D-1895

Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products -- Content and Format; Draft Guidance for Industry; Availability

RIN
—
Last modified
Sep 10, 2018
Comment window
closed 2881d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Sep 6, 2018 and Sep 6, 2018. 1 other organizations filed here. The comment window closed 2881d ago.

What American Pharmacists Association (APhA) filed (1)

Sep 6, 2018· Comment from American Pharmacists Association (APhA)· FDA-2018-D-1895-0004

Please see attached for comments from the American Pharmacists Association.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (1)

See everyone who commented →
Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products -- Content and Format; Draft Guidance for Industry; Availability (FDA) — American Pharmacists Association (APhA) | OpenPolis